Literature DB >> 29883676

Polymicrogyria in association with hypoglycemia points to mutation in the mTOR pathway.

Chloe Stutterd1, George McGillivray2, Zornitza Stark3, Betty Messazos4, Fergus Cameron4, Sue White5, Ghayda Mirzaa6, Richard Leventer7.   

Abstract

We report a 16-month-old male with congenital megalencephaly, polymicrogyria and persistent hypoglycemia caused by a mosaic PIK3CA pathogenic variant. Hypoinsulinaemic, hypoketotic hypoglycaemia is a rare complication of pathogenic variants in the PI3K-AKT-mTOR pathway genes including AKT2, AKT3, CCND2, PIK3R2 and PIK3CA, and has been identified in a PIK3CA mutant mouse model. Our case highlights the importance of considering PI3K-AKT-mTOR pathway variants as a cause for megalencephaly and cortical malformation when the phenotype includes hypoglycaemia. Recognizing the association of hypoglycemia with PI3K-AKT-mTOR pathway variants can provide a clue to the genetic basis of the cortical malformation. Patients with megalencephaly and a cortical malformation may be considered at risk of hypoglycaemia and monitored accordingly, at least until a PI3K-AKT-mTOR pathway variant has been excluded.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Hypoglycemia; Megalencephaly; Phosphatidylinositol 3-Kinases; Polymicrogyria

Mesh:

Substances:

Year:  2018        PMID: 29883676     DOI: 10.1016/j.ejmg.2018.06.002

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  3 in total

1.  Growth hormone deficiency in megalencephaly-capillary malformation syndrome: An association with activating mutations in PIK3CA.

Authors:  Shanlee Davis; Meredith A Ware; Jordan Zeiger; Matthew A Deardorff; Katheryn Grand; Adda Grimberg; Stephanie Hsu; Megan Kelsey; Shideh Majidi; Revi P Matthew; Melanie Napier; Natalie Nokoff; Chitra Prasad; Andrew C Riggs; Margaret L McKinnon; Ghayda Mirzaa
Journal:  Am J Med Genet A       Date:  2019-11-15       Impact factor: 2.802

Review 2.  Hypoglycemia due to PI3K/AKT/mTOR signaling pathway defects: two novel cases and review of the literature.

Authors:  Evelina Maines; Roberto Franceschi; Diego Martinelli; Fiorenza Soli; Francesca Romana Lepri; Giovanni Piccoli; Massimo Soffiati
Journal:  Hormones (Athens)       Date:  2021-04-20       Impact factor: 2.885

Review 3.  A standard of care for individuals with PIK3CA-related disorders: An international expert consensus statement.

Authors:  Sofia Douzgou; Myfanwy Rawson; Eulalia Baselga; Moise Danielpour; Laurence Faivre; Alon Kashanian; Kim M Keppler-Noreuil; Paul Kuentz; Grazia M S Mancini; Marie-Cecile Maniere; Victor Martinez-Glez; Victoria E Parker; Robert K Semple; Siddharth Srivastava; Pierre Vabres; Marie-Claire Y De Wit; John M Graham; Jill Clayton-Smith; Ghayda M Mirzaa; Leslie G Biesecker
Journal:  Clin Genet       Date:  2021-07-16       Impact factor: 4.296

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.